Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ammar Sarwar, MD
Director of Radiation Oncology Research, Beth Israel Deaconess Medical Center
Principal Investigator - Andrew Kennedy, MD
Director, Radiation Oncology Research at Sarah Cannon
Principal Investigator - Aravind Arepally, MD
ABK Biomedical, Inc
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Vancouver Coastal Health Research Institution (vchri)
Vancouver, British Columbia, Canada
- the University of Arizona Cancer Center
Tucson, Arizona, United States
- University of California - Irvine
Orange, California, United States
- Adventhealth Radiation Oncology at Altamonte Springs
Altamonte Springs, Florida, United States
- Miami Cardiac and Vascular Institute at Baptist Hospital Miami
Miami, Florida, United States
- Emory University Hospital Midtown
Atlanta, Georgia, United States
- Piedmont Hospital
Atlanta, Georgia, United States
- Northwestern University Memorial Hospital
Chicago, Illinois, United States
- University of Illinois Hospital and Health Sciences System
Chicago, Illinois, United States
- University of Iowa Health Care
Iowa City, Iowa, United States
- University of Louisville
Louisville, Kentucky, United States
- Ochsner Clinic Foundation
New Orleans, Louisiana, United States
- Beth Israel Deaconess
Boston, Massachusetts, United States
- University of Missouri - Ellis Fischel Cancer Center
Columbia, Missouri, United States
- Ssm Health Saint Louis University
St Louis, Missouri, United States
- Weill Cornell Medicine-New York Presbyterian Hospital
New York, New York, United States
- Charlotte Radiology
Charlotte, North Carolina, United States
- Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Hca Healthcare Research Institute (sarah Cannon)
Nashville, Tennessee, United States
- University of Utah
Salt Lake City, Utah, United States
- Inland Imaging
Spokane, Washington, United States
- Froedtert Hospital/medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Sept 2023
- Primary completion
- 28 Feb 2027
- Completion
- 28 Feb 2027
- Last update posted
- 4 Mar 2026
- Registered enrollment
- 120
- Registry id
- NCT05953337
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.